Core Viewpoint - Lifeward Ltd. and MYOLYN, Inc. are expanding their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use, aiming to improve rehabilitation for individuals with physical limitations or disabilities [1][2][3] Company Overview - Lifeward is a global leader in innovative medical technology focused on transforming the lives of individuals with physical limitations or disabilities, with a portfolio that includes products like the ReWalk Exoskeleton and the MyoCycle FES System [4] - MYOLYN specializes in functional electrical stimulation therapy, with its flagship product, the MyoCycle, designed to provide therapeutic exercise for individuals with muscle weakness or paralysis [6] Partnership Expansion - The new contract allows Lifeward to manage referrals and sales of the MyoCycle Home product for patients transitioning from clinical to home use, building on an existing distribution agreement for hospital and clinic-based sales [2][3] - MYOLYN will continue to service patients already discharged from therapy, focusing on maximizing their health and recovery through home FES cycling programs [2] Strategic Goals - The partnership aims to better serve patients who have completed therapy in clinics and wish to continue rehabilitation at home, leveraging Lifeward's case management infrastructure to support anticipated growth in the MyoCycle product line [3]
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use